Dr. Rochon obtained her Ph.D. in the Department of Communication Sciences and Disorders at McGill University, where her doctoral dissertation was on sentence comprehension impairments in Alzheimer's Disease. She subsequently completed a postdoctoral fellowship at Moss Rehabilitation Research Institute, Moss Rehab Hospital (Philadelphia, PA), where she worked with Dr. Myrna Schwartz and colleagues. At Moss, she continued her studies of language comprehension impairments in Alzheimer's Disease, in addition to working on a large project designed to evaluate a new treatment ("mapping therapy") for individuals with nonfluent aphasia. Previous to joining the Department of Speech-Language Pathology at the University of Toronto, Dr. Rochon was Silverman Scientist in the Kunin-Lunenfeld Clinical Research Unit and the Department of Communication Disorders at Baycrest in Toronto. Dr. Rochon is a Senior Scientist and member of the Communication Research Team at Toronto Rehab. Dr. Rochon is also an Associate Member of the Heart and Stroke Foundation Canadian Partnership for Stroke Recovery.